DO Dow Jones Newswires Theravance Biopharma Shareholders to Receive $17 Per Shr in Cash, Representing an Equity Value of $929M >TBPH 6/29/2026, 06:00 PM GMT+8 Dow Jones Newswires TB TBPH ZY ZYME Sources Dow Jones Newswires Markets corp_bond, Stocks Active symbols NASDAQ:TBPH, NASDAQ:ZYME Language English Theravance Biopharma Shareholders to Receive $17 Per Shr in Cash, Representing an Equity Value of $929M >TBPH Market News Dow Jones Newswires Zymeworks Is Maintained at Overweight by Wells Fargo Reuters Mergers and acquisitions TradingView Key facts: Zymeworks to buy Theravance for $17/share; CVR, layoffs TradingView Zymeworks Inc. Stock 12‑Month Price Target Raised to $38.75, Implies 60% Upside
